stockportfolio.pro
Stocks / CNMD vs TNDM
CNMD vs TNDM
CONMED Corporation and Tandem Diabetes Care, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| CONMED Corporation (CNMD) | Tandem Diabetes Care, Inc. (TNDM) | |
|---|---|---|
| Market cap | $1.1B | $1.1B |
| Revenue (latest FY) | $1.37B | $1.01B |
| Net income (latest FY) | $47.05M | $-204.71M |
| Revenue growth (5y CAGR) | 9.8% | 15.3% |
| Net margin | 3.4% | -20.2% |
| Return on equity | 4.6% | -131.9% |
| P/E ratio | 20.4 | — |
| Dividend yield | 2.2% | — |
| Profitable years (of last 10) | 9 | 1 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CNMD — free Open TNDM — freeFrequently asked questions
Which is bigger, CNMD or TNDM?
Tandem Diabetes Care, Inc. is larger by market capitalization — $1.1B versus $1.1B.
Which grows faster, CNMD or TNDM?
Over the last five fiscal years, Tandem Diabetes Care, Inc. grew revenue faster — 15.3%/yr versus 9.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.